Satsuma Pharmaceuticals Inc expected to post a loss of 48  cents a share - Earnings Preview

Satsuma Pharmaceuticals

06/05/2022 19:36

* Satsuma Pharmaceuticals Inc  STSA.OQ   STSA.O  is expected
to show no change in quarterly revenue when it reports 
results on May 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Satsuma
Pharmaceuticals
Inc is for a loss of 48 cents per share. For the same quarter
last year, the company reported a loss of 48 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $15​, above​ its last closing price
of $3.79. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021              -0.48      -0.49     Missed  -1
 Sep. 30 2021              -0.51      -0.42     Beat    17.6
 Jun. 30 2021  -0.41       -0.41      -0.38     Beat    8.1​
 Mar. 31 2021  -0.41       -0.42      -0.48     Missed  -15.2
 ​​Dec.        -0.65       -0.53      -0.72     Missed  -36.2
 31 2020                                                
 Sep. 30 2020  -0.75       -0.69      -0.69     Met     0.7​
 Jun. 30 2020  -0.71       -0.71      -0.65     Beat    8.9
 Mar. 31 2020  -0.67       -0.67      -0.68     Missed  -1.5
 This summary was machine generated May 6 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated